Odysight.ai Reports Q1 2025 Revenue Increase to $2.1 Million, Bolstered by Medical Contract Fulfillment

ODYS
September 19, 2025
Odysight.ai Inc. announced its financial results for the three months ended March 31, 2025, on May 15, 2025, reporting revenues of approximately $2.1 million. This marks a significant increase from $0.2 million in the first quarter of 2024, primarily attributed to the full recognition of approximately $1.7 million in revenues from the fulfillment of a contract with a Fortune 500 medical company. Gross profit for Q1 2025 was $0.6 million, reflecting a gross margin of 26%, an improvement from a gross loss of $0.2 million in the prior year's quarter. Operating expenses rose to $5.1 million, up from $3.1 million, driven by the expansion of operations, new Industry 4.0 product development, and one-time expenses related to the Nasdaq uplisting. The net loss for the quarter was $4.3 million, compared to $3.2 million in Q1 2024. As of March 31, 2025, the company's cash balance stood at $37.2 million, significantly higher than $17.0 million a year prior, following the February 2025 Nasdaq uplisting and public offering which generated approximately $23.7 million in gross proceeds. The backlog was approximately $14.8 million as of March 31, 2025. The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.